TheEdgeResearch
Home / Stocks / GCAN

Trafalgar International, Inc. (GCAN)

OTC Healthcare Medical - Pharmaceuticals
$1.60 ▲ +0.00%
Market Cap
$318,200
Sector
Healthcare
Industry
Medical - Pharmaceuticals
Beta
0.34
52-Wk Range
0.18-3.36
CEO
Porfirio Sánchez-Talavera
Country
US
Currency
USD

Trafalgar International, Inc. operates in the Medical - Pharmaceuticals industry of the Healthcare sector, headquartered in Miami, FL, US. The stock last traded at $1.60, up 0.00% on the session, giving a market capitalisation of $318,200. On trailing twelve-month figures it carries a trailing P/E of 0.38, a net margin of 0.0%. Its beta of 0.34 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
0.38
Price / Sales
0.00
Price / Book
0.00
EV / EBITDA
-3.00
Gross margin
0.0%
Operating margin
0.0%
Net margin
0.0%
Return on equity
—
Debt / equity
0.00
Current ratio
0.00
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
1
IPO date
2018-09-18
Headquarters
Miami, FL, US
About Trafalgar International, Inc.

Trafalgar International, Inc. focuses on acquiring, developing and growing businesses in the financial services, technology and intellectual property sectors. The company was formerly known as The Greater Cannabis Company, Inc. and changed its name to Trafalgar International, Inc. in July 2026. The company was founded in 2014 and is based in Miami, Florida.

Comparable companies

Trafalgar International, Inc. is most often compared with the following Healthcare names:

ADVTBBBTCANLEAPHGREHINLBREZNFSETOTRCNFWRHLF
More research on GCAN
GCAN technical analysis GCAN TheEdge Score Compare against peers
Open full interactive analysis & DCF →